Flavocure Biotech Inc. is a leading biotechnology company based in Baltimore, MD, specializing in the transformation of natural products into innovative cures for patients. With a focus on oncology, Flavocure has discovered several promising drug candidates that are being advanced through clinical research in collaboration with prestigious research institutions worldwide. Their lead drug candidate, Caflanone, has received FDA Orphan Drug Designation for pancreatic cancer and has shown activity against various cancers, including glioblastoma, acute myeloid leukemia, and multiple myeloma.
Driven by a mission to address the urgent need for transformative therapies, Flavocure Biotech is dedicated to developing next-generation solutions inspired by nature. Their research focus areas include pancreatic cancer, glioblastoma, myeloma, and acute myeloid leukemia. With a team of experienced leaders and strategic research collaborations with top academic institutions, Flavocure is actively seeking partnering opportunities with pharmaceutical and biotechnology companies to expand their portfolio and make a significant impact in the field of cancer treatment.
Generated from the website